Dr. Sarbjit Saini, MD

Dr. Saini practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Saini's NPI, 1942235148, was assigned on July 12, 2006. Dr. Saini graduated from Ohio State University College of Medicine in 1991. Dr. Saini holds Maryland license D48040.

Dr. Saini's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Saini's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Saini is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saini practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Saini's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Saini is licensed in Maryland.

CMS data shows 78 Medicare services from Dr. Saini across 4 procedure codes in 2024, for 48 Medicare patients. Medicare paid $5,179 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Saini in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Saini's median patient age at 70, with 72% women.

In 2024, Dr. Saini wrote 54 Medicare Part D claims for 13 patients. 76% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $154 in total drug cost. In 2019, CMS named 39 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Saini for performance year 2024, reported as part of a group. CMS lists Dr. Saini as offering telehealth.

Dmand AI links 58 papers to Dr. Saini, published from 2011 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Omalizumab, Urticaria and Anti-Allergic Agents. Dr. Saini has published most often in J Allergy Clin Immunol. Dr. Saini's most frequent co-authors are Eric Tyrell Oliver, MD, Jonathan A. Bernstein, MD and Allen P. Kaplan, MDMD.

Dmand AI links Dr. Saini to 6 clinical trials, 2 of them phase 4 studies. Conditions studied include Chronic Urticaria, Urticaria and Rhinitis, Allergic. Johns Hopkins University sponsors the most, 3. Open Payments lists research payments to Dr. Saini that name 3 trials.

CMS Open Payments shows 124 general payments to Dr. Saini from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $43,642. It also lists 53 research payments totaling $50,953 from 2016 to 2025, naming 3 clinical trials.

Dr. Saini graduated from Ohio State University College of Medicine in 1991.